A randomized, 2-period, crossover, pharmacodynamic comparability study comparing a pantoprazole spheroid formulation to the currently marketed tablet formulation in subjects with GERD [gastro-esophageal reflux disease] and a history of erosive esophagitis

Trial Profile

A randomized, 2-period, crossover, pharmacodynamic comparability study comparing a pantoprazole spheroid formulation to the currently marketed tablet formulation in subjects with GERD [gastro-esophageal reflux disease] and a history of erosive esophagitis

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Feb 2013

At a glance

  • Drugs Pantoprazole (Primary)
  • Indications Erosive oesophagitis; Gastro-oesophageal reflux
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Feb 2013 Actual end date added 1 Nov 2005 as reported by ClinicalTrials.gov record.
    • 23 Aug 2007 Results reported.
    • 25 May 2007 Status change from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top